Nutex Health (NASDAQ:NUTX) Shares Down 6.7% – Time to Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s share price fell 6.7% on Wednesday . The company traded as low as $158.10 and last traded at $156.9680. Approximately 45,679 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 173,837 shares. The stock had previously closed at $168.27.

Analyst Ratings Changes

Several brokerages have recently issued reports on NUTX. Weiss Ratings lowered Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, July 10th. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. B. Riley Financial assumed coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price target for the company. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday. Finally, Lake Street Capital assumed coverage on Nutex Health in a report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $243.33.

Nutex Health Stock Down 2.3%

The firm has a market cap of $1.06 billion, a P/E ratio of 11.87 and a beta of 0.21. The firm has a fifty day moving average of $151.15 and a 200-day moving average of $130.55. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. The company had revenue of $216.49 million during the quarter, compared to the consensus estimate of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. On average, equities research analysts anticipate that Nutex Health Inc. will post 22.72 earnings per share for the current year.

Institutional Trading of Nutex Health

Several hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE grew its holdings in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Nutex Health by 17.9% in the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after acquiring an additional 2,748 shares in the last quarter. Jane Street Group LLC acquired a new position in shares of Nutex Health in the first quarter valued at about $522,000. JPMorgan Chase & Co. increased its position in Nutex Health by 41,430.0% during the second quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock worth $1,034,000 after acquiring an additional 8,286 shares during the period. Finally, Legal & General Group Plc acquired a new stake in Nutex Health in the 2nd quarter worth about $454,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.